Otros idiomas Otsuka Holdings Co., Ltd.

Acciones

4578

JP3188220002

Mercado cerrado - Japan Exchange Otros sitios de cotización 08:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
6.370 ^JPY	+1,56 %		+2,97 %	+20,44 %

09/04	H. Lundbeck y Otsuka Pharmaceutical buscan el visto bueno de la FDA estadounidense para una terapia combinada contra el TEPT	MT
27/03	La Comisión Europea da luz verde a Abilify Maintena de Lundbeck y Otsuka como tratamiento de mantenimiento de la esquizofrenia	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy	09/04
Bourses asiatiques: Tokyo mi-figue, mi-raisin, Hong Kong confiante	02/04
Otsuka Holdings Disposes of 2.32 Billion Yen Worth of Shares as Restricted Stock Compensation	29/03
EU Commission Green-lights Lundbeck, Otsuka's Abilify Maintena as Maintenance Treatment of Schizophrenia	27/03
Sumitomo Pharma Amends Collaboration Agreement with Otsuka Pharmaceutical	18/03
VIE STYLE, Inc. announced that it has received ¥305 million in funding from Otsuka Holdings Co., Ltd., KAYAC Inc., Taisho Pharmaceutical Holdings Co., Ltd., Towa Pharmaceutical Co., Ltd., PE&HR Co., Ltd., Murata Manufacturing Co., Ltd. and other investors	07/03
IBio Sells Preclinical PD-1 Antagonist Antibody Program to Otsuka	26/02
Otsuka Holdings' Attributable Profit Down 9.2% 2023 On Impairment Losses	16/02
Otsuka Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending December 31, 2024	16/02
Otsuka Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending December 31, 2024	16/02
MÄRKTE ASIEN/Schwach - Zinssenkungshoffnungen schwinden	14/02
MÄRKTE ASIEN/Leichter nach US-Dämpfer für Zinssenkungshoffnungen	14/02
Otsuka Holdings Co., Ltd. Announces Year-End Dividend for the Year Ended December 31, 2023, Payable on March 29 , 2024; Provides Second Quarter-End Dividend Guidance for the Fiscal Year 2024	14/02
Otsuka Holdings Lowers 2023 Profit Outlook	13/02
Japan's Nikkei cruises to 34-year peak, briefly breaching 38,000 range	13/02
Japan's Nikkei soars to 34-year high on chip shares, earnings	13/02
Phase 3 Trial for Otsuka's Alzheimer's-related Agitation Treatment Fails to Meet Primary Endpoint	13/02
Otsuka's drug for Alzheimer's disease agitation fails in late stage study	13/02
Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ended December 31, 2023	13/02
Otsuka Group Selected for CDP Climate Change a List for a Second Consecutive Year	08/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Otsuka Holdings Co., Ltd.

Acciones

4578

JP3188220002

Otros idiomas

Filtros